Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2017

Jul 7, 2017

34023_dirs_2017-07-07_2ce587b2-4ea0-4890-b5de-90634edd07a6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2017-06-29

Reporting Person: Buell Jennifer (VP Research & External Affairs)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 24361 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option, right to buy $3.68 2023-09-03 Common Stock (32500) Direct
Restricted Stock Unit $0 2017-09-03 Common Stock (4375) Direct
Stock Option, right to buy $3 2024-02-14 Common Stock (100000) Direct
Stock Option, right to buy $5.04 2025-02-12 Common Stock (24500) Direct
Stock Option, right to buy $5.04 2025-02-12 Common Stock (10500) Direct
Restricted Stock Unit $0 2019-03-31 Common Stock (16000) Direct
Stock Option, right to buy $4.16 2026-03-31 Common Stock (100000) Direct
Stock Option, right to buy $3.77 2027-03-31 Common Stock (125000) Direct

Footnotes

F1: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan vesting in 4 equal annual installments beginning September 3, 2014, the first anniversary of the grant date.

F2: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan vesting in 12 quarterly installments from February 12, 2015, the date of grant.

F3: Award granted in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and is eligible to vest in a single installment on March 31, 2019 based upon Company stock price performance. Amount shown reflects the target award. The ultimate award size can range between 50% and 150% of the target based on the actual average stock price achieved.

F4: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests over three years with one-third vested on March 31, 2017 and the balance in equal quarterly installments thereafter.

F5: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan vesting one-third on the one-year anniversary of the grant date, March 31, 2017, with the balance vesting in equal quarterly installments thereafter.